Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluvastatin/Fenofibrate vs Simvastatin/Ezetimibe in Metabolic Syndrome
NCT00385658Phase 4Completed
- Sponsor
- Novartis
- Start
- Aug 2006
- Primary completion
- Mar 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of fluvastatin, fenofibrate in dyslipidemia, metabolic syndrome, sponsored by Novartis. Started Aug 2006; status: completed.
02
Drugs
fluvastatinfenofibrate
03
Conditions
dyslipidemiametabolic syndrome
Beyond the preview
Go deeper on NCT00385658.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00385658.